Weight problems evaluate: World Well being Group weighs in on weight reduction medication (NYSE:NVO)


Semaglutide pen

Douglas Cliff/iStock through Getty Pictures

The healthcare trade could also be turning a nook close to weight reduction and persistent weight problems as a brand new technology of highly-effective medication proceed to make headlines. These GLP-1 agonists, like Novo Nordisk’s (NVO) Wegovy, in addition to Eli Lilly’s (



Supply hyperlink

We will be happy to hear your thoughts

Leave a reply

Fitness Products
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart